 HIGHLANDS RANCH, Colo., Dec. 15, 2020 GLOBE NEWSWIRE -- Vivos Therapeutics, Inc. Vivos today announced the closing of its initial public offering of 4,025,000 shares of its common stock. The offering consisted of 3,500,000 shares of its common stock, as well as an additional 525,000 shares pursuant to the exercise in full of the underwriters option to purchase additional shares of common stock, at a public offering price of 6.00 per share. Vivos common stock is listed on the Nasdaq Capital Market under the ticker symbol VVOS. 